User profiles for Jean-Luc Vanderheyden

Jean-Luc Vanderheyden

JLVMI Consulting LLC
Verified email at jlvmi.com
Cited by 4550

The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine

E Deutsch, K Libson, JL Vanderheyden… - International Journal of …, 1986 - Elsevier
The β emitting isotopes 186 Re and 188 Re are logical choices on which to base
therapeutic radiopharmaceuticals that might be expected to be analogous to diagnostic …

Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque

…, D Hartung, N Steinmetz, JL Vanderheyden… - Circulation, 2003 - Am Heart Assoc
Background— Apoptosis is common in advanced human atheroma and contributes to
plaque instability. Because annexin V has a high affinity for exposed phosphatidylserine on …

Apoptosis-detecting radioligands: current state of the art and future perspectives

CMM Lahorte, JL Vanderheyden, N Steinmetz… - European journal of …, 2004 - Springer
This review provides a critical and thorough overview of the radiopharmaceutical development
and in vivo evaluation of all apoptosis-detecting radioligands that have emerged so far, …

Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application

…, ND Steinmetz, JL Vanderheyden… - Journal of Nuclear …, 2003 - Soc Nuclear Med
99m Tc-hydrazinonicotinamido (HYNIC)-annexin V is a novel tracer for in vivo imaging of
apoptosis. The present study on humans was performed to investigate the safety of 99m Tc-…

Quantitative tumor apoptosis imaging using technetium-99m–HYNIC annexin V single photon emission computed tomography

…, ND Steinmetz, JL Vanderheyden… - Journal of clinical …, 2003 - ascopubs.org
Purpose: Radiolabeled annexin V may allow for repetitive and selective in vivo identification
of apoptotic cell death without the need for invasive biopsy. This study reports on the …

Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats

…, AL Spijkerboer, JL Vanderheyden… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Anthracyclines are widely used in chemotherapy regimens for several malignancies, with
cardiotoxicity being the major limiting factor in high-dose schedules. Recently, it was reported …

Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods

…, FG Blankenberg, JL Vanderheyden - Journal of Nuclear …, 2006 - Soc Nuclear Med
Labeled annexin V is widely used to detect cell death in vitro and in vivo. Nearly all studies
have been done with annexin V derivatized via amine-directed bifunctional agents; it was …

99mTc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials

…, MS Kartachova, LW Stitt, JL Vanderheyden… - European journal of …, 2015 - Springer
Purpose 99m Tc-Annexin A5 has been used as a molecular imaging probe for the visualization,
characterization and measurement of apoptosis. In an effort to define the quantitative …

The future of SPECT in a time of PET

FP Jansen, JL Vanderheyden - Nuclear medicine and biology, 2007 - Elsevier
As positron emission tomography (PET) imaging is becoming more prevalent in clinical
practice, it is reasonable to ask if there will be a role for single photon emission computed …

99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody

…, ML Goris, A Green, JL Vanderheyden… - European journal of …, 2006 - Springer
Purpose The first aim of the study was to determine whether 99m Tc-HYNIC-annexin V, a
marker of cellular stress and apoptosis, can detect ischemic injury in patients with acute stroke. …